$1.81
+0.04
(+2.26%)▲
3.59%
Downside
Day's Volatility :4.64%
Upside
1.09%
22.1%
Downside
52 Weeks Volatility :64.03%
Upside
53.83%
Period | Talkspace Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -31.42% | 4.7% | 0.0% |
6 Months | -38.7% | 5.1% | 0.0% |
1 Year | 11.87% | 16.6% | 0.0% |
3 Years | -64.2% | 15.6% | -20.6% |
Market Capitalization | 301.1M |
Book Value | $0.68 |
Earnings Per Share (EPS) | -0.05 |
Wall Street Target Price | 3.5 |
Profit Margin | -4.44% |
Operating Margin TTM | -7.57% |
Return On Assets TTM | -5.89% |
Return On Equity TTM | -6.55% |
Revenue TTM | 172.5M |
Revenue Per Share TTM | 1.03 |
Quarterly Revenue Growth YOY | 29.2% |
Gross Profit TTM | 53.7M |
EBITDA | -11.9M |
Diluted Eps TTM | -0.05 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.05 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 93.37%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 38.2M | - |
Net Income | -29.1M | - |
Net Profit Margin | -76.19% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 76.2M | ↑ 99.57% |
Net Income | -22.4M | ↓ 23.09% |
Net Profit Margin | -29.36% | ↑ 46.83% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 113.7M | ↑ 49.19% |
Net Income | -62.7M | ↑ 180.47% |
Net Profit Margin | -55.2% | ↓ 25.84% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 119.6M | ↑ 5.19% |
Net Income | -79.7M | ↑ 26.98% |
Net Profit Margin | -66.63% | ↓ 11.43% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 150.0M | ↑ 25.49% |
Net Income | -19.2M | ↓ 75.92% |
Net Profit Margin | -12.78% | ↑ 53.85% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 33.3M | ↑ 10.23% |
Net Income | -8.8M | ↓ 52.16% |
Net Profit Margin | -26.27% | ↑ 34.27% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 35.6M | ↑ 6.93% |
Net Income | -4.7M | ↓ 46.29% |
Net Profit Margin | -13.2% | ↑ 13.07% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 38.6M | ↑ 8.42% |
Net Income | -4.4M | ↓ 6.16% |
Net Profit Margin | -11.42% | ↑ 1.78% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 42.4M | ↑ 9.76% |
Net Income | -1.3M | ↓ 70.41% |
Net Profit Margin | -3.08% | ↑ 8.34% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 45.4M | ↑ 7.07% |
Net Income | -1.5M | ↑ 12.25% |
Net Profit Margin | -3.23% | ↓ 0.15% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 46.1M | ↑ 1.41% |
Net Income | -474.0K | ↓ 67.67% |
Net Profit Margin | -1.03% | ↑ 2.2% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 41.9M | - |
Total Liabilities | 121.5M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 32.9M | ↓ 21.6% |
Total Liabilities | 131.8M | ↑ 8.43% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 223.6M | ↑ 580.21% |
Total Liabilities | 31.3M | ↓ 76.22% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 156.3M | ↓ 30.12% |
Total Liabilities | 28.7M | ↓ 8.35% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 142.2M | ↓ 8.98% |
Total Liabilities | 23.6M | ↓ 17.91% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 144.8M | ↓ 7.34% |
Total Liabilities | 23.1M | ↓ 19.41% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 140.5M | ↓ 2.94% |
Total Liabilities | 20.7M | ↓ 10.44% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 140.3M | ↓ 0.12% |
Total Liabilities | 22.6M | ↑ 9.17% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 142.2M | ↑ 1.33% |
Total Liabilities | 23.6M | ↑ 4.19% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 138.3M | ↓ 2.77% |
Total Liabilities | 18.7M | ↓ 20.69% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 133.8M | ↓ 3.24% |
Total Liabilities | 19.7M | ↑ 5.6% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -16.8M | - |
Investing Cash Flow | -527.0K | - |
Financing Cash Flow | 56.0K | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -21.2M | ↑ 26.14% |
Investing Cash Flow | -138.0K | ↓ 73.81% |
Financing Cash Flow | 51.5M | ↑ 91866.07% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -15.2M | ↓ 28.39% |
Investing Cash Flow | -11.3M | ↑ 8090.58% |
Financing Cash Flow | 94.0K | ↓ 99.82% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -65.7M | ↑ 333.02% |
Investing Cash Flow | -663.0K | ↓ 94.13% |
Financing Cash Flow | 251.4M | ↑ 267327.66% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -61.1M | ↓ 7.05% |
Investing Cash Flow | -317.0K | ↓ 52.19% |
Financing Cash Flow | 1.7M | ↓ 99.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -14.0M | ↓ 1.29% |
Investing Cash Flow | 19.0K | ↓ 130.16% |
Financing Cash Flow | 556.0K | ↑ 192.63% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 289.0K | ↓ 102.06% |
Investing Cash Flow | -1000.0 | ↓ 105.26% |
Financing Cash Flow | 733.0K | ↑ 31.83% |
Sell
Neutral
Buy
Talkspace Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Talkspace Inc | 7.19% | -38.7% | 11.87% | -64.2% | -78.99% |
Solventum Corp | 14.71% | -4.2% | -4.2% | -4.2% | -4.2% |
Doximity, Inc. | 3.98% | 31.19% | 60.09% | -64.38% | -31.43% |
Veeva Systems Inc. | 16.43% | -5.21% | -4.01% | -28.71% | 48.77% |
Ge Healthcare Technologies Inc. | 3.3% | -8.51% | 27.72% | 40.67% | 40.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Talkspace Inc | 0.82 | NA | NA | 0.0 | -0.07 | -0.06 | NA | 0.68 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Doximity, Inc. | 45.43 | 45.43 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
Veeva Systems Inc. | 57.42 | 57.42 | 1.39 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 25.23 | 25.23 | 2.26 | 4.24 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Talkspace Inc | Buy | $301.1M | -78.99% | 0.82 | -4.44% |
Solventum Corp | Hold | $10.8B | -4.2% | NA | 15.73% |
Doximity, Inc. | Hold | $6.7B | -31.43% | 45.43 | 32.53% |
Veeva Systems Inc. | Buy | $35.0B | 48.77% | 57.42 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $39.9B | 40.67% | 25.23 | 8.1% |
Insights on Talkspace Inc
Revenue is up for the last 8 quarters, 29.33M → 46.05M (in $), with an average increase of 6.2% per quarter
Netprofit is up for the last 2 quarters, -1.46M → -474.0K (in $), with an average increase of 209.3% per quarter
In the last 1 year, Doximity, Inc. has given 60.2% return, outperforming this stock by 47.6%
NVP Associates LLC
Hudson Executive Capital LP
BlackRock Inc
Revolution Growth Management Company, Inc.
Shannon River Fund Management LLC
Vanguard Group Inc
therapy for the way we live today. a new york-based online therapy start-up, our mission at talkspace is to make therapy affordable and accessible to everyone. we have a network of professional, licensed therapists available for consultations and long-term treatment plans, all via your smartphone or the web. just like an office visit, your conversations are 100% confidential in your secure chat room. your therapist is waiting to help you make a real, lasting difference in your life. you can message your therapist anytime and anywhere, from your smartphone or the web, 100% safe and secure. welcome to the wonderful world of therapy, re-invented for how we live today. talkspace homepage: www.talkspace.com more on online therapy: http://www.talkspace.com/online-therapy/
Organization | Talkspace Inc |
Employees | 472 |
CEO | Dr. Jon R. Cohen M.D. |
Industry | Specialty Telecommunications |
A Spac I Acquisition Corp
$1.81
+2.26%
Keyarch Acquisition Corp
$1.81
+2.26%
Connexa Sports Technologies Inc
$1.81
+2.26%
Us Value Etf
$1.81
+2.26%
First Wave Biopharma Inc
$1.81
+2.26%
Global X Msci Next Emerging
$1.81
+2.26%
Fat Projects Acquisition Corp
$1.81
+2.26%
Capital Link Global Fintech
$1.81
+2.26%
Applied Uv Inc
$1.81
+2.26%